Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials

SIMPLE SUMMARY: Timely execution and reporting of cancer clinical trials is important to patients and clinical researchers. Looking at a group of over three hundred cancer clinical trials with published results, we studied what factors influenced how quickly they reported their results in scientific...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Lin, Timothy A., Fuller, Clifton David, Verma, Vivek, Mainwaring, Walker, Espinoza, Andres F., Miller, Austin B., Jethanandani, Amit, Pasalic, Dario, Das, Prajnan, Minsky, Bruce D., Thomas, Charles R., Fogelman, David R., Subbiah, Vivek, Subbiah, Ishwaria M., Ludmir, Ethan B.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Brief Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7563891/
https://ncbi.nlm.nih.gov/pubmed/32947844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092636
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky